With gene therapy closing in on hemophilia, BioMarin expands in North Bay – San Francisco Business Times
San Francisco Business Times |
With gene therapy closing in on hemophilia, BioMarin expands in North Bay
San Francisco Business Times The San Rafael-based rare disease drug company reported good data for its experimental gene therapy to correct hemophilia A. Now as it closes in on a pivotal study, it is expanding its manufacturing site in Novato. |
